“Exciting Announcement: Enterprise Support Scheme (“ESS”) of the Innovation and Technology Fund (“ITF”) has Approved Funding for our project titled ‘Developing a Quantitative Gene Co-Expression Test (QGCT) for Chemoresistance of High-Grade Serous Ovarian Cancer (HGSOC)’ on 1st November 2023.”

Exciting Announcement: Enterprise Support Scheme (“ESS”) of the Innovation and Technology Fund (“ITF”) has Approved Funding for our project titled ‘Developing a Quantitative Gene Co-Expression Test (QGCT) for Chemoresistance of High-Grade Serous Ovarian Cancer (HGSOC)’ on 1st November 2023.

Prev Post

We Are Pleased To Announce That We Received A Written Opinion Of The International Search Authority Of The Patent Cooperation Treaty (PCT)
Next Post

“Significant Success: Prof. Benjamin Yung Delivered an Insightful and Impactful Talk on ‘Mission Possible: NPM/B23 Gene Gene Co-expressions Uncover the Origins of Cancer (All Disease)’ in November 2023 in Taipei at the Department of Bioscience Technology, Chung Yuan Christian University of Taiwan.”